Meyka AI API is live for developers.Start building.
Advertisement
BeOne Medicines Ltd.

BeOne Medicines Ltd. (ONC) Stock Overview

Explore BeOne Medicines Ltd.’s financial performance, market position, analyst ratings, and future outlook.

ONC●NASDAQ
HealthcareMedical - Pharmaceuticals
$263.38
$4.80(1.79%)
U.S. Market opens in 17h 12m
Advertisement

BeOne Medicines Ltd. (ONC)

Meyka AI Score

Z

Key Financials

Market Cap28.2B
P/E Ratio58.26
EPS (TTM)$4.42
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$284.92
3 Months$298.91
1 Year Target$372.30

ONC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BeOne Medicines Ltd. (ONC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 32.53, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $372.30.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 58.26 and a market capitalization of 28.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.70%
5-Day Change
-4.20%
1-Month Change
-15.54%
3-Month Change
-13.68%
6-Month Change
-18.31%
Year-to-Date (YTD) Change
-13.23%
1-Year Change
0.07%
3-Year Change
23.64%
5-Year Change
-25.32%
All-Time (Max) Change
830.83%

Contact Information

https://beonemedicines.com
345-949-4123
NaN, NaN, NaN, NaN

Company Facts

11,000 Employees
IPO DateFeb 2, 2016
CountryUS
Actively Trading

Frequently Asked Questions